AAA Acquires GE Healthcare's FDG-PET Radiopharmaceutical Business in Italy
Advanced Accelerator Applications (“AAA” or “the Company”), an international specialist in Molecular Nuclear Medicine (MNM) announced today that it has entered into an agreement with GE Healthcare Italy to acquire their FDG-PET business (fluorodeoxyglucose photon emission tomography). This acquisition includes the SteriPET® (FDG) Marketing Licence. With this acquisition AAA reinforces its position as one of the leading companies in the PET market in Italy.
View full press release